Genomatica is a widely-recognized technology leader for the chemical industry. It delivers new manufacturing processes that enable its partners to produce the world’s most widely-used chemicals from alternative feedstocks, with better economics and greater sustainability than petroleum-based processes. 

Genomatica’s first process, for the production of BDO, is commercial. Our GENO BDO™ process has been licensed by BASF and by Novamont; BASF has announced its first commercial production; over nine million pounds have been produced to date; and multiple large chemical firms have publicly validated quality and/or described commercialization plans, including Invista (for its well-known Lycra® spandex), DSM, Lanxess, Toray, and Far Eastern New Century.

Genomatica’s second set of processes is for butadiene, with Versalis and Braskem as anchor partners, and over $100 million in industry support.

Genomatica’s third set of processes is for nylon intermediates, including hexamethylenediamine, caprolactam and adipic acid (HMD, CPL and ADA).

We develop our processes using our proprietary, integrated biotechnology platform. Our processes are designed to convert a range of alternative feedstocks into numerous target chemicals that meet industry specifications for large, established markets. Our platform combines process engineering with predictive computational modeling and advanced experimental laboratory technology in a unique systems-based approach. This allows us to develop highly efficient manufacturing processes faster than traditional process development methods. Our development speed and process efficiency were validated by the successful commercial-scale production of BDO using our process in less than five years. Our intellectual property currently targets processes to produce over 20 intermediate and basic chemicals, including our commercial GENO BDO process and the processes for butadiene and nylon intermediates that we are developing.

We work with industry leaders to accelerate broad and rapid commercial adoption of our processes. To date, we have announced partnerships with BASFNovamont, Versalis, and Braskem.

We have raised $125 million in financing from Alloy Ventures, Bright Capital, Draper Fisher Jurvetson, Mitsubishi Chemical, Mohr Davidow Ventures, TPG Biotech, VantagePoint Capital Partners, Versalis and Waste Management.

Genomatica’s recognition includes the Wall Street Journal Technology Innovation award, ICIS Top 40 ‘Ones to Watch’, the Kirkpatrick Award, the EPA Presidential Green Chemistry Challenge Award, voted #1 Hottest three years in a row by Biofuels Digest, and being named a Best Place to Work by The Scientist two years in a row.

 

Chemicals produced using Genomatica’s processes should have better economics and a smaller environmental footprint than petroleum-based chemicals.